BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Celtaxsys, Inc. 

ATDC Biosciences Center
311 Ferst Drive
Atlanta  Georgia  30332  U.S.A.
Phone: 404-920-0700 Fax: 404-920-0701


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Celtaxsys, Inc. Initiates First Clinical Trial of Oral CTX-4430 Therapy in Cystic Fibrosis Patients 10/11/2013 9:02:03 AM    More...
Celtaxsys, Inc. Announces Successful Completion of Phase 1 Clinical Trial for Development of CTX-4430 9/17/2013 8:30:32 AM    More...
Celtaxsys, Inc. Restructures Management and Operations; CEO, CTO Out 9/10/2013 7:15:22 AM    More...
Celtaxsys, Inc. Appoints Khalil Barrage to Board of Directors 4/19/2013 7:46:33 AM    More...
Celtaxsys, Inc. Initiates Phase 1 Study of CTX-4430 Oral Treatment for Pulmonary Inflammation 1/3/2013 9:49:44 AM    More...
Brett Premack, Ph.D. Joins Celtaxsys, Inc. as Chief Technology Officer 10/24/2012 8:50:19 AM    More...
Celtaxsys, Inc. Acquires Clinical Stage Innate Immunity Drug for Inflammation 1/5/2012 3:01:59 PM    More...
Dr. H. Daniel Perez Joins Celtaxsys, Inc. Board of Directors 6/6/2011 1:25:00 PM    More...
Dr. Michael Hanley Joins Celtaxsys, Inc. as CEO 12/3/2010 7:09:34 AM    More...
Celtaxsys, Inc. Seeks $10 Million to Develop Immune System Drugs; Raises $4.2 Million So Far 11/5/2010 6:54:10 AM    More...
12

//-->